chloramphenicol gppl chloramphenicol 5 mg/ml eyedrops bottle
arrotex pharmaceuticals pty ltd - chloramphenicol, quantity: 5 mg/ml - eye drops - excipient ingredients: phenylmercuric nitrate; borax; boric acid; water for injections - for the treatment of bacterial conjunctivitis. for use under medical supervision only in the treatment of other superficial ocular infections caused by chloramphenicol sensitive organisms.
chloramphenicol ah chloramphenicol 5 mg/ml eyedrops bottle
juno pharmaceuticals pty ltd - chloramphenicol, quantity: 5 mg/ml - eye drops - excipient ingredients: water for injections; boric acid; borax; phenylmercuric nitrate - for the treatment of bacterial conjunctivitis. for use under medical supervision only in the treatment of other superficial ocular infections caused by chloramphenicol sensitive organisms.
chloramphenicol vuab 1 g.
david margalit & co.ltd - chloramphenicol as sodium succinate - powder for concentrate for solution for injection - chloramphenicol as sodium succinate 1 g - chloramphenicol - typhus and parathyphus, salmonellosis with septic development, meningitis, epiglottis, pertussis and parapertussis, serious infections with aerobe and anaerobe flora (pulmonary, abdominal, gynecologic) and other infections caused by bacteria susceptible to chloramphenicol.
chloramphenicol sodium succinate- chloramphenicol sodium succinate injection, powder, lyophilized, for solution
fresenius kabi usa, llc - chloramphenicol sodium succinate (unii: 872109hx6b) (chloramphenicol - unii:66974fr9q1) - chloramphenicol 1 g in 10 ml - in accord with the concepts in the warning box and this indications and usage section, chloramphenicol must be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated. however, chloramphenicol may be chosen to initiate antibiotic therapy on the clinical impression that one of the conditions below is believed to be present; in vitro sensitivity tests should be performed concurrently so that the drug may be discontinued as soon as possible if less potentially dangerous agents are indicated by such tests. the decision to continue use of chloramphenicol rather than another antibiotic when both are suggested by in vitro studies to be effective against a specific pathogen should be based upon severity of the infection, susceptibility of the pathogen to the various antimicrobial drugs, efficacy of the various drugs in the infection, and the important additional conce
chloramphenicol 0.5% eye drops
a a h pharmaceuticals ltd - chloramphenicol - eye drops - 5mg/1ml
chloramphenicol 0.5% eye drops
the boots company plc - chloramphenicol - eye drops - 5mg/1ml
chloramphenicol 0.5% eye drops
almus pharmaceuticals ltd - chloramphenicol - eye drops - 5mg/1ml
chloramphenicol 0.5% eye drops
vantage - chloramphenicol - eye drops - 5mg/1ml
chloramphenicol 0.5% eye drops
dowelhurst ltd - chloramphenicol - eye drops - 5mg/1ml
chloramphenicol 0.5% eye drops
strides pharma uk ltd - chloramphenicol - eye drops - 5mg/1ml